正文 穀氨酸脫羧酶抗體滴度與糖尿病患者胰島功能關係的研究(2 / 2)

本文隨機選取入院137例既往初診為2型糖尿病患者進行GAD-Ab檢測,並在血糖控製達(8~10) mmol/L左右時進行胰島功能檢測,基本排除了由於高糖毒性作用所導致胰島功能異常的影響,研究結果顯示:① GAD-Ab陽性12例,陽性率8.76%(既往文獻報道陽性率7.1%~11.8%),僅有2例糖尿病家族史陽性;②GAD-Ab陽性組特征:發病年齡偏小、體重指數較陰性組偏低、空腹及餐後2 h血清C肽水平低(P

[參考文獻]

[1] Grp L,Miettinen A,Grp PH,et al. Orang-specific autimmunity and HLA-DR antigens as markers for B-cell destrucitin in patients with tipe I diabetes[J]. Diabetes,1998,37(1):99-102.

[2] 李霞,黃幹. 成人隱匿性自身免疫糖尿病患者胰島素抵抗與穀氨酸脫羧酶抗體滴度的關係[J]. 南方醫科大學學報,2012,30(6):75.

[3] Turner R,Stratton I,Horton V,et al. UKPDS 25 autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes[J]. Lancet,1997,350(12):88-93.

[4] 楊琳,周智廣,黃幹,等. LADA患者胰島β細胞功能的前瞻性研究[J]. 中華內分泌代謝雜誌,2003,19(4):163.

[5] 何君欽,林麗香,陳明欽. 糖尿病患者穀氨酸脫羧酶自身抗體測定的臨床意義[J]. 中華內分泌代謝雜誌,1997,13(2):97-99.

[6] Kobayashi T,Nakanishi K,Murase Y,et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive betacell failure in islet cell antibodypositive patients with clinical features of NIDDM[J]. Diabetes,1996,45(6):622.

[7] Kobayashi T,Mauyama T,Schimada A,et al. Insulin in tervention to preserve beta cells in slowly progressiveinsu lin dependent(type 1)diabetes mellitus[J]. Ann NY Acad Sci,2002,958(30):117.

(收稿日期:2012-02-06)